Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
[This corrects the article DOI: 10.1016/j.ekir.2025.01.023.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266208 | PMC |
| http://dx.doi.org/10.1016/j.ekir.2025.05.025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.
Front Oncol
August 2025
Medical Oncology, Healthcare Global, Bangalore, India.
[This corrects the article DOI: 10.3389/fonc.2025.
View Article and Find Full Text PDFJ Rheumatol 2024; doi: 10.3899/jrheum.2024-0298 Following the initial publication of this article, the study team became aware of additional nonserious adverse events (AEs) that occurred during the long-term extension study.
View Article and Find Full Text PDFCorrection: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.
J Neurol
August 2025
Clinical Investigation Center CIC1436, Departments of Neurosciences and Clinical Pharmacology and NS-Park/FCRIN Network, University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France.
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [ Volume 10, Issue 4, April 2025, Pages 1063-1075].
Kidney Int Rep
July 2025
Division of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
[This corrects the article DOI: 10.1016/j.ekir.
View Article and Find Full Text PDF